Search

Lexicon Pharmaceuticals Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

2.31 -1.28

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.29

Max

2.35

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-32M

-33M

Pardavimai

-20M

692K

Pelnas, tenkantis vienai akcijai

-0.06

Pelno marža

-4,742.486

Darbuotojai

81

EBITDA

-30M

-29M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+156.41% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-05

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-2.7M

1B

Ankstesnė atidarymo kaina

3.59

Ankstesnė uždarymo kaina

2.31

Naujienos nuotaikos

By Acuity

50%

50%

167 / 340 reitingas Healthcare

Lexicon Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-24 19:36; UTC

News

Lexicon Pharmaceuticals received a $10 million milestone payment from Novo Nordisk, bringing total payments to $75 million as shares rise during Monday's session.

2026-08-21 19:36; UTC

Lexicon Pharmaceuticals Inc shares are higher in Friday's session, continuing an upward trend since Thursday. The stock remains below its 20-day moving average.

2026-08-20 23:56; UTC

Lexicon Pharmaceuticals Inc shares are rising in after-market trading, showing positive momentum despite being below their 20-day moving average. No specific news was identified.

2026-08-18 19:31; UTC

Lexicon Pharmaceuticals Inc shares are higher today, driven by significant gains in the Biotechnology sub-sector. The stock is near its one-month high.

2026-08-13 19:56; UTC

Lexicon Pharmaceuticals is trading lower today amid no specific news. First-time claims for U.S. unemployment benefits rose, but investor sentiment remains stable.

2026-08-12 23:36; UTC

Lexicon Pharmaceuticals Inc's shares are higher in after-market trading, with no specific news identified. Broader market sentiment may be influenced by recent inflation data.

2026-08-11 23:26; UTC

Lexicon Pharmaceuticals Inc. shares are lower in after-market trading, with no specific news identified. Broader market sentiment remains cautious amid oil price developments.

2026-08-10 19:56; UTC

News

Lexicon Pharmaceuticals reported a second-quarter earnings loss of -$0.06 per share, missing expectations. Shares are lower amid a downgrade to “sell” from Wall Street Zen.

2026-08-07 22:01; UTC

Lexicon Pharmaceuticals Inc shares are lower in after-market hours, continuing a notable decline since Friday's close, with no specific news identified to explain the movement.

2026-08-06 23:26; UTC

Lexicon Pharmaceuticals shares are trading higher in after-market hours, following three consecutive sessions of declines. No specific news was identified for the price movement.

2026-08-05 19:36; UTC

News

Lexicon Pharmaceuticals Inc shares are lower as investors adjust positions ahead of Q2 earnings on August 5, with consensus EPS estimates at -$0.05.

2026-08-04 19:56; UTC

Lexicon Pharmaceuticals shares are higher today, reflecting strong momentum amid easing inflation concerns from declining crude oil prices. No specific news was identified.

2026-07-31 19:46; UTC

Lexicon Pharmaceuticals Inc shares are lower today, reflecting broader market trends amid rising yields and crude oil prices contributing to inflation concerns.

2026-07-30 23:11; UTC

Lexicon Pharmaceuticals Inc shares are lower in after-market hours. The decline follows broader market uncertainty after the Federal Reserve's interest rate decision.

2026-07-29 21:02; UTC

Lexicon Pharmaceuticals Inc shares are lower in after-market trading, reflecting broader market declines amid rising oil prices and geopolitical tensions in the Middle East.

2026-07-27 19:03; UTC

Lexicon Pharmaceuticals Inc is trading lower today, breaking a trend of higher daily closes. Broader market declines and falling oil prices may influence sentiment.

2026-07-24 20:07; UTC

Lexicon Pharmaceuticals Inc shares are lower today, reversing from earlier gains amid broader market volatility influenced by falling oil prices and inflation concerns.

2026-07-22 19:02; UTC

Lexicon Pharmaceuticals Inc shares are lower today, continuing a decline since Tuesday's close. The stock remains below its 20-day moving average.

2026-07-21 19:42; UTC

Lexicon Pharmaceuticals is higher as the market gains momentum, driven by strong performances from major companies and a resurgence in semiconductor stocks.

2026-07-20 19:06; UTC

Lexicon Pharmaceuticals Inc shares are lower today, following three days of gains. Broader market declines are linked to rising US Treasury yields and oil prices above $90.

Akcijų palyginimas

Kainos pokytis

Lexicon Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

156.41% į viršų

12 mėnesių prognozė

Vidutinis 6 USD  156.41%

Aukščiausias 6 USD

Žemiausias 6 USD

Remiantis 2 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Lexicon Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

2 ratings

2

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

167 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
help-icon Live chat